When embarking on a path that few have ventured before, it's natural to be inundated with questions. The use of ketamine as a treatment for neuropathic pain and behavioral health disorders, particularly Treatment Resistant Depression (TRD), is still in its early stages. Therefore, the journey of starting your own ketamine business or clinic is no different and is filled with challenges and learning curves. 

In the world of mental health treatment, innovative approaches are continually emerging to address the complex landscape of conditions such as depression, anxiety, and PTSD. One such approach gaining traction is Ketamine-Assisted Psychotherapy (KAP).

Living with mental illness can be exhausting, overwhelming, and incredibly difficult. Finding the right treatment can be just as challenging. Fortunately, there is a powerful combination of Ketamine and NAD therapy that can help those struggling with mental illness.

Episode 341: ketamine therapy

Theo Von invites Dr. Jason Pooler, founder and medical director of the Chattanooga Ketamine Center, to provide his insights between Ketamine Therapy and depression. 

In a previous blog entry, we wrote about the ketamine infusion experience. Let me expand on that today, as I focus on recovery from ketamine infusion therapy. 

Memorial Day         

What time are we eating!? What can we bring!? Will the kids swim!? Oh, what a bummer that it’s raining…we were gonna take the boat out! 

While you might be seasoning meat to grill, making potato salad, drinking beer, slathering sunscreen on your kids’ faces, or just enjoying a long weekend, take a moment to remember the men and women who died while serving in the Armed Forces.

Seriously…Ketamine!?

Its notoriety as a rave drug jolts folks a bit, when they hear that ketamine is being used to treat refractory depression. Yes, ketamine…the ‘horse tranquilizer’ the drug that has taken many down the ‘K-hole’. That one. Over the past couple decades, scientists have conducted numerous studies that have repeatedly and consistently revealed the efficacy of low-dose ketamine infusions in treating depression in people for whom standard pharmacological treatments have not worked. Ketamine was developed in 1962 and has been used as a general anesthetic for more than 30 years. The drug has a remarkably safe track record when used in clinical settings and is on the World Health Organization’s List of Essential Medicines. Ketamine is FDA-approved as an anesthetic, but research continues to inform us that low doses of ketamine, administered intravenously, can produce rapid antidepressant effects.